Skip to main content

Table 1 Baseline characteristics of the study population

From: Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease

Characteristics

Patients (n = 281)

Demographics

 

Age (years)

57.97 ± 9.55

Men [n (%)]

199 (70.8)

BMI (kg/m2)

25.96 ± 3.42

Coronary risk factors

 

Hypertension [n (%)]

190 (67.6)

Diabetes [n (%)]

75 (26.7)

Dyslipidemia [n (%)]

197 (70.1)

Smoking [n (%)]

139 (49.5)

Family history of CAD [n (%)]

52 (18.5)

Laboratory parameters

 

TC (mg/dl)

190.23 ± 43.09

TG (mg/dl)

147.79 (104.87-207.96)

Non-HDL-C (mg/dl)

147.77 ± 41.85

Apo A-I (g/L)

1.39 ± 0.26

Apo B (g/L)

1.00 ± 0.28

LDL-C (mg/dl)

122.91 ± 38.87

 Large LDL-C (mg/dl)

27.76 ± 9.66

 Intermediate LDL-C (mg/dl)

20.81 ± 9.26

 Small LDL-C (mg/dl)

9.29 ± 9.97

LDL score (% of sd-LDL)

14.48 ± 13.56

 Mean LDL size (Å)

266.06 ± 6.10

 HDL-C (mg/dl)

42.46 ± 14.68

 Large HDL-C (mg/dl)

13.70 ± 7.50

 Intermediate HDL-C (mg/dl)

20.90 ± 7.35

 Small HDL-C (mg/dl)

8.17 ± 3.49

ALT (U/L)

24.92 ± 17.34

AST (U/L)

18.54 ± 8.72

ALP (IU/L)

64.67 ± 17.78

GGT (IU/L)

33.56 ± 23.96

Cr (μmol/L)

72.38 ± 16.63

BUN (mmol/L)

5.94 ± 1.47

PCSK9 (ng/ml)

215.53 (180.14-260.39)

  1. The data shown are the mean ± SD, median (Q1-Q3 quartiles) or n (%).
  2. BMI: body mass index. CAD: coronary artery disease. TC: total cholesterol. TG: triglycerides. Non-HDL-C: non high-density lipoprotein cholesterol. ApoA-I: apolipoprotein A1. ApoB: apolipoprotein B. LDL-C: low-density lipoprotein-cholesterol. HDL-C: high-density lipoprotein cholesterol. ALT: alanine aminotransferase. AST: aspartate aminotransferase. ALP: alkaline phosphatase. GGT: glutamyl transferase. Cr: creatinine. BUN: blood urea nitrogen. PSCK9: proprotein convertase subtilisin kexin type 9.